ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
ClearPoint Neuro Q2 2024 GAAP EPS $(0.16) Beats $(0.20) Estimate, Sales $7.858M Beat $7.330M Estimate
clearpoint neuro 第二季度2024年GAAP每股收益为$(0.16)，超过$(0.20)的估计，销售额为$7,858,000，超过$7,330,000的估计。
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 44.83 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $7.858 million which beat the analyst consensus estimate of $7.330 million by 7.21 percent. This is a 32.07 percent increase over sales of $5.950 million the same period last year.
ClearPoint Neuro (纳斯达克：CLPT) 报告季度亏损每股 $(0.16)，超过分析师预期的 $(0.20) 的20%。这比去年同期每股亏损 $(0.29) 增加了 44.83%。该公司报告的季度销售额为 $785.8万，比分析师预期的 $733万 高了 7.21%。这是去年同期销售额 $595万 的增长了 32.07%。